pcDNA3.1-IDH2-WT Citations (2)

Originally described in: Replication Study: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.
Showalter MR, Hatakeyama J, Cajka T, VanderVorst K, Carraway KL, Fiehn O Elife. 2017 Jun 27;6. pii: e26030. doi: 10.7554/eLife.26030. PubMed Journal

---

Articles Citing pcDNA3.1-IDH2-WT

Articles
TM7SF3 controls TEAD1 splicing to prevent MASH-induced liver fibrosis. Isaac R, Bandyopadhyay G, Rohm TV, Kang S, Wang J, Pokhrel N, Sakane S, Zapata R, Libster AM, Vinik Y, Berhan A, Kisseleva T, Borok Z, Zick Y, Telese F, Webster NJG, Olefsky JM. Cell Metab. 2024 May 7;36(5):1030-1043.e7. doi: 10.1016/j.cmet.2024.04.003. Epub 2024 Apr 25. PubMed
Opportunistic pathogen Porphyromonas gingivalis targets the LC3B-ceramide complex and mediates lethal mitophagy resistance in oral tumors. Sheridan M, Chowdhury N, Wellslager B, Oleinik N, Kassir MF, Lee HG, Engevik M, Peterson Y, Pandruvada S, Szulc ZM, Yilmaz O, Ogretmen B. iScience. 2024 Apr 30;27(6):109860. doi: 10.1016/j.isci.2024.109860. eCollection 2024 Jun 21. PubMed

If you have published an article using this material, please email us at to have your article added to this page.